Приказ основних података о документу

Karakterizacija Intor:Swiss soja albino miševa donetog u Institut za virusologiju, vakcine i serume - Torlak početkom XX veka

dc.creatorŽivković, Irena
dc.creatorRajnpreht, Irena
dc.creatorMinić, Rajna
dc.creatorMitić, Katarina
dc.creatorAleksić, Iva
dc.creatorKadrić, Jasminka
dc.creatorPetrušić, Vladimir
dc.date.accessioned2021-04-20T12:49:32Z
dc.date.available2021-04-20T12:49:32Z
dc.date.issued2016
dc.identifier.issn0567-8315
dc.identifier.urihttp://rimi.imi.bg.ac.rs/handle/123456789/733
dc.description.abstractThe Institute of Virology, Vaccines and Sera Torlak was established in 1927, while the first vaccine was produced in the Institute in 1930. Vaccines production implies using experimental animals, including mice, in in-process controls. The laboratory mice which have been in use in Torlak Institute from the very beginning belong to Swiss albino outbred stock. This stock, which has been in use for more than 80 years contains a large number of mice maintained at all times, was recently named Intor:Swiss. Biological characteristics of Intor:Swiss stock, are presented in this paper for the first time. Taking into account the presented characteristics, the Institute Torlak's Swiss mice are suitable for use in pharmaceutical studies, vaccine development research and basic research, as well as in toxicological studies. The publication of data on the Intor:Swiss mice represents a contribution to the international scientific community, since it offers the possibility for obtaining an additional outbred mouse stock for research.en
dc.description.abstractInstitut za Virusologiju, vakcine i serume Torlak, osnovan je 1927., a prva vakcina u Institutu proizvedena je 1930. Proizvodnja vakcina je složen proces koji između ostalog podrazumeva i korišćenje eksperimentalnih životinja u kontroli samog procesa. Laboratorijski miševi koji su od samog početka bili u upotrebi u Institutu Torlak, pripadaju Swiss albino outbred soju. Ova kolonija je u upotrebi više od 80 godina i sve vreme se sastoji od velikog broja jedinki što omogućava očuvanje genetske raznolikosti, pa samim tim i outbred karakteristika. Ovi miševi su odnedavno registrovani pod imenom Intor:Swiss, i njihove biološke osobine su u ovom radu prikazane po prvi put. Swiss miševi Instituta Torlak pogodni su za upotrebu u farmaceutskim studijama, za razvojno istraživanje vakcina, osnovna istraživanja i toksikološka ispitivanja. Zbog svega navedenog Intor:Swiss miševi predstavljaju još jedan pogodan animalni model za ispitivanje lekova i vakcina.sr
dc.publisherUniverzitet u Beogradu - Fakultet veterinarske medicine, Beograd
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172049/RS//
dc.rightsopenAccess
dc.sourceActa Veterinaria-Beograd
dc.subjectlaboratory animalsen
dc.subjectoutbtreden
dc.subjectSwiss miceen
dc.subjectIgG2cen
dc.titleCharacterization of Intor:Swiss albino mice adopted in the Institute of virology, vaccines and sera: Torlak, Belgrade in the early twentieth centuryen
dc.titleKarakterizacija Intor:Swiss soja albino miševa donetog u Institut za virusologiju, vakcine i serume - Torlak početkom XX vekasr
dc.typearticle
dc.rights.licenseARR
dc.citation.epage293
dc.citation.issue3
dc.citation.other66(3): 279-293
dc.citation.spage279
dc.citation.volume66
dc.identifier.doi10.1515/acve-2016-0025
dc.identifier.fulltexthttp://rimi.imi.bg.ac.rs/bitstream/id/556/730.pdf
dc.identifier.scopus2-s2.0-84992214351
dc.identifier.wos000384771100001
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу